Skip to main content
. 2020 Mar 28;141(23):1841–1854. doi: 10.1161/CIRCULATIONAHA.120.046448

Table 3.

Outcomes in Patients With Diabetes Mellitus (Untreated and Treated With Hypoglycemic Agents) and Without Diabetes Mellitus for Rivaroxaban Plus Aspirin Versus Placebo Plus Aspirin

graphic file with name cir-141-1841-g007.jpg